Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02653651Phase 4Completed
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (3 arms), sponsored by University of Tunis El Manar. Primary endpoint: Total opioid consumption at 24 hours. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02653651.